Axsome Therapeutics
AXSM
AXSM
190 hedge funds and large institutions have $1.99B invested in Axsome Therapeutics in 2020 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 68 increasing their positions, 48 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.8% more ownership
Funds ownership: 61.61% → 65.41% (+3.8%)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
25% less call options, than puts
Call options by funds: $51.7M | Put options by funds: $69M
Holders
190
Holding in Top 10
6
Calls
$51.7M
Puts
$69M
Top Buyers
| 1 | +$49.8M | |
| 2 | +$44.4M | |
| 3 | +$42.9M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$28.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$27.9M |
Top Sellers
| 1 | -$47.7M | |
| 2 | -$35M | |
| 3 | -$25.2M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$22.7M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$18M |